Concept Life Sciences has a team of immunology experts that helps its clients understand their targets' and compounds' MOA (mechanisms of action) and immunomodulatory effects to progress their drug discovery pipeline.
We can help you understand your target’s and/or compound’s mechanism of action to progress your drug discovery pipeline. We offer collaborative experimental design and can advise on the most suitable cell types, mono- or co-culture assays. By tailoring, customizing and developing assays to suit your requirements, we can build a data package that is right for you.
We offer a tailored program of work and data you can trust, giving you greater confidence in your lead compound selection and accelerating your best route to clinic.
Data packages that suit our clients’ requirements
We offer a collaborative and robust experimental design approach and can guide on the most suitable immune cell types, in mono- or co-culture assays. We tailor and develop assays to build data packages that suit our clients’ requirements.
We design exploratory studies to identify where targets are expressed and undertake the fundamental work to help identify a lead compound’s MOA.
We offer a wide range of in vitro and in vivo assays and design experiments with tailored readouts such as FACS, ELISA, multiplex and RNA-seq to suit your requirements. This in vitro approach can mimic the tumor immune cell environment (TME), a specific autoimmune condition and neurodegenerative disease.
Our experienced team offer a tailored program of work and data our clients can trust, giving them greater confidence in lead compound selection and accelerating the best route to clinic.
Assays for all immune cell types
- Mixed lymphocyte reactions (MLRs)
- PBMC and T cell stimulation assays
- Exhausted T cell assay
- Killing assays
- Suppression assays
- Phagocytosis assays
- Myeloid cell assay